P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML

Bibliographic Details
Main Authors: M. Kienhöfer, C. Pauli, S. Delaunay, C. Rohde, M. F. Blank, D. Heid, M. Frye, C. Müller-Tidow
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000844544.25273.14
_version_ 1797287867758673920
author M. Kienhöfer
C. Pauli
S. Delaunay
C. Rohde
M. F. Blank
D. Heid
M. Frye
C. Müller-Tidow
author_facet M. Kienhöfer
C. Pauli
S. Delaunay
C. Rohde
M. F. Blank
D. Heid
M. Frye
C. Müller-Tidow
author_sort M. Kienhöfer
collection DOAJ
first_indexed 2024-03-07T18:40:56Z
format Article
id doaj.art-ea6ceb9f1a424edba81095d7ad517e70
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T18:40:56Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-ea6ceb9f1a424edba81095d7ad517e702024-03-02T03:51:57ZengWileyHemaSphere2572-92412022-06-01631431510.1097/01.HS9.0000844544.25273.14202206003-00314P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AMLM. Kienhöfer0C. Pauli1S. Delaunay2C. Rohde3M. F. Blank4D. Heid5M. Frye6C. Müller-Tidow71 Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg1 Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg2 German Cancer Research Center (DKFZ)1 Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg1 Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg1 Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg2 German Cancer Research Center (DKFZ)1 Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberghttp://journals.lww.com/10.1097/01.HS9.0000844544.25273.14
spellingShingle M. Kienhöfer
C. Pauli
S. Delaunay
C. Rohde
M. F. Blank
D. Heid
M. Frye
C. Müller-Tidow
P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML
HemaSphere
title P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML
title_full P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML
title_fullStr P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML
title_full_unstemmed P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML
title_short P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML
title_sort p414 rna modification focused crispr cas9 screen reveals potential therapeutic targets mediating chemoresistance in aml
url http://journals.lww.com/10.1097/01.HS9.0000844544.25273.14
work_keys_str_mv AT mkienhofer p414rnamodificationfocusedcrisprcas9screenrevealspotentialtherapeutictargetsmediatingchemoresistanceinaml
AT cpauli p414rnamodificationfocusedcrisprcas9screenrevealspotentialtherapeutictargetsmediatingchemoresistanceinaml
AT sdelaunay p414rnamodificationfocusedcrisprcas9screenrevealspotentialtherapeutictargetsmediatingchemoresistanceinaml
AT crohde p414rnamodificationfocusedcrisprcas9screenrevealspotentialtherapeutictargetsmediatingchemoresistanceinaml
AT mfblank p414rnamodificationfocusedcrisprcas9screenrevealspotentialtherapeutictargetsmediatingchemoresistanceinaml
AT dheid p414rnamodificationfocusedcrisprcas9screenrevealspotentialtherapeutictargetsmediatingchemoresistanceinaml
AT mfrye p414rnamodificationfocusedcrisprcas9screenrevealspotentialtherapeutictargetsmediatingchemoresistanceinaml
AT cmullertidow p414rnamodificationfocusedcrisprcas9screenrevealspotentialtherapeutictargetsmediatingchemoresistanceinaml